Additive manufacturing of pharmaceuticals for precision medicine applications: A review of the promises and perils in implementation

Megha Trivedi, Joann Jee, Suzanila Silva, Carmel Blomgren, Vasco M. Pontinha, Dave L. Dixon, Benjamin Van Tassel, Michael J. Bortner, Christopher Williams, Eric Gilmer, Alexander P. Haring, Justin Halper, Blake N. Johnson, Zhenyu Kong, Matthew S. Halquist, Paul F. Rocheleau, Timothy Edward Long, Thomas Roper, Dayanjan S. Wijesinghe

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Precision medicine is an emerging field in healthcare that seeks to tailor preventive and therapeutic strategies to the unique physiology, biochemistry, lifestyles, and genetics of individual patients. There are several technologies that are key to the successful delivery of precision medicine including pharmacogenomics, pharmacometabolomics, improved point-of-care testing, and therapeutically-tailored medications. The inclusion of additive manufacturing (AM) technology, more commonly known as 3D printing, in the manufacture of oral dosage forms such as tablets, provides an avenue for the implementation of precision medicine in current healthcare practice via the prescription of specific dosage forms and drug combinations tailored to individual needs. Widespread commercialization of AM of pharmaceuticals has the potential to disrupt the supply chain used by the healthcare industry worldwide with the cost-saving potential of minimizing waste related to unused, expired medications. Despite the potential of this technology, many clinical and regulatory challenges will need to be addressed prior to large-scale implementation of AM fabricated therapeutics for precision medicine applications. This review investigates both the potential and the challenges of delivering AM fabricated medications for therapeutic use in precision medicine applications.

Original languageEnglish
Pages (from-to)319-328
Number of pages10
JournalAdditive Manufacturing
Volume23
DOIs
Publication statusPublished - 2018 Oct 1
Externally publishedYes

Fingerprint

3D printers
Drug products
Medicine
Pharmaceutical Preparations
Dosage Forms
Biochemistry
Bioelectric potentials
Physiology
Drug Combinations
Supply chains
Tablets
Printing
Testing
Costs
Industry

ASJC Scopus subject areas

  • Biomedical Engineering
  • Materials Science(all)
  • Engineering (miscellaneous)
  • Industrial and Manufacturing Engineering

Cite this

Additive manufacturing of pharmaceuticals for precision medicine applications : A review of the promises and perils in implementation. / Trivedi, Megha; Jee, Joann; Silva, Suzanila; Blomgren, Carmel; Pontinha, Vasco M.; Dixon, Dave L.; Van Tassel, Benjamin; Bortner, Michael J.; Williams, Christopher; Gilmer, Eric; Haring, Alexander P.; Halper, Justin; Johnson, Blake N.; Kong, Zhenyu; Halquist, Matthew S.; Rocheleau, Paul F.; Long, Timothy Edward; Roper, Thomas; Wijesinghe, Dayanjan S.

In: Additive Manufacturing, Vol. 23, 01.10.2018, p. 319-328.

Research output: Contribution to journalReview article

Trivedi, M, Jee, J, Silva, S, Blomgren, C, Pontinha, VM, Dixon, DL, Van Tassel, B, Bortner, MJ, Williams, C, Gilmer, E, Haring, AP, Halper, J, Johnson, BN, Kong, Z, Halquist, MS, Rocheleau, PF, Long, TE, Roper, T & Wijesinghe, DS 2018, 'Additive manufacturing of pharmaceuticals for precision medicine applications: A review of the promises and perils in implementation', Additive Manufacturing, vol. 23, pp. 319-328. https://doi.org/10.1016/j.addma.2018.07.004
Trivedi, Megha ; Jee, Joann ; Silva, Suzanila ; Blomgren, Carmel ; Pontinha, Vasco M. ; Dixon, Dave L. ; Van Tassel, Benjamin ; Bortner, Michael J. ; Williams, Christopher ; Gilmer, Eric ; Haring, Alexander P. ; Halper, Justin ; Johnson, Blake N. ; Kong, Zhenyu ; Halquist, Matthew S. ; Rocheleau, Paul F. ; Long, Timothy Edward ; Roper, Thomas ; Wijesinghe, Dayanjan S. / Additive manufacturing of pharmaceuticals for precision medicine applications : A review of the promises and perils in implementation. In: Additive Manufacturing. 2018 ; Vol. 23. pp. 319-328.
@article{d9a057b4d4d54a5c8e62ea30f9d30839,
title = "Additive manufacturing of pharmaceuticals for precision medicine applications: A review of the promises and perils in implementation",
abstract = "Precision medicine is an emerging field in healthcare that seeks to tailor preventive and therapeutic strategies to the unique physiology, biochemistry, lifestyles, and genetics of individual patients. There are several technologies that are key to the successful delivery of precision medicine including pharmacogenomics, pharmacometabolomics, improved point-of-care testing, and therapeutically-tailored medications. The inclusion of additive manufacturing (AM) technology, more commonly known as 3D printing, in the manufacture of oral dosage forms such as tablets, provides an avenue for the implementation of precision medicine in current healthcare practice via the prescription of specific dosage forms and drug combinations tailored to individual needs. Widespread commercialization of AM of pharmaceuticals has the potential to disrupt the supply chain used by the healthcare industry worldwide with the cost-saving potential of minimizing waste related to unused, expired medications. Despite the potential of this technology, many clinical and regulatory challenges will need to be addressed prior to large-scale implementation of AM fabricated therapeutics for precision medicine applications. This review investigates both the potential and the challenges of delivering AM fabricated medications for therapeutic use in precision medicine applications.",
author = "Megha Trivedi and Joann Jee and Suzanila Silva and Carmel Blomgren and Pontinha, {Vasco M.} and Dixon, {Dave L.} and {Van Tassel}, Benjamin and Bortner, {Michael J.} and Christopher Williams and Eric Gilmer and Haring, {Alexander P.} and Justin Halper and Johnson, {Blake N.} and Zhenyu Kong and Halquist, {Matthew S.} and Rocheleau, {Paul F.} and Long, {Timothy Edward} and Thomas Roper and Wijesinghe, {Dayanjan S.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.addma.2018.07.004",
language = "English",
volume = "23",
pages = "319--328",
journal = "Additive Manufacturing",
issn = "2214-8604",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Additive manufacturing of pharmaceuticals for precision medicine applications

T2 - A review of the promises and perils in implementation

AU - Trivedi, Megha

AU - Jee, Joann

AU - Silva, Suzanila

AU - Blomgren, Carmel

AU - Pontinha, Vasco M.

AU - Dixon, Dave L.

AU - Van Tassel, Benjamin

AU - Bortner, Michael J.

AU - Williams, Christopher

AU - Gilmer, Eric

AU - Haring, Alexander P.

AU - Halper, Justin

AU - Johnson, Blake N.

AU - Kong, Zhenyu

AU - Halquist, Matthew S.

AU - Rocheleau, Paul F.

AU - Long, Timothy Edward

AU - Roper, Thomas

AU - Wijesinghe, Dayanjan S.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Precision medicine is an emerging field in healthcare that seeks to tailor preventive and therapeutic strategies to the unique physiology, biochemistry, lifestyles, and genetics of individual patients. There are several technologies that are key to the successful delivery of precision medicine including pharmacogenomics, pharmacometabolomics, improved point-of-care testing, and therapeutically-tailored medications. The inclusion of additive manufacturing (AM) technology, more commonly known as 3D printing, in the manufacture of oral dosage forms such as tablets, provides an avenue for the implementation of precision medicine in current healthcare practice via the prescription of specific dosage forms and drug combinations tailored to individual needs. Widespread commercialization of AM of pharmaceuticals has the potential to disrupt the supply chain used by the healthcare industry worldwide with the cost-saving potential of minimizing waste related to unused, expired medications. Despite the potential of this technology, many clinical and regulatory challenges will need to be addressed prior to large-scale implementation of AM fabricated therapeutics for precision medicine applications. This review investigates both the potential and the challenges of delivering AM fabricated medications for therapeutic use in precision medicine applications.

AB - Precision medicine is an emerging field in healthcare that seeks to tailor preventive and therapeutic strategies to the unique physiology, biochemistry, lifestyles, and genetics of individual patients. There are several technologies that are key to the successful delivery of precision medicine including pharmacogenomics, pharmacometabolomics, improved point-of-care testing, and therapeutically-tailored medications. The inclusion of additive manufacturing (AM) technology, more commonly known as 3D printing, in the manufacture of oral dosage forms such as tablets, provides an avenue for the implementation of precision medicine in current healthcare practice via the prescription of specific dosage forms and drug combinations tailored to individual needs. Widespread commercialization of AM of pharmaceuticals has the potential to disrupt the supply chain used by the healthcare industry worldwide with the cost-saving potential of minimizing waste related to unused, expired medications. Despite the potential of this technology, many clinical and regulatory challenges will need to be addressed prior to large-scale implementation of AM fabricated therapeutics for precision medicine applications. This review investigates both the potential and the challenges of delivering AM fabricated medications for therapeutic use in precision medicine applications.

UR - http://www.scopus.com/inward/record.url?scp=85052479458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052479458&partnerID=8YFLogxK

U2 - 10.1016/j.addma.2018.07.004

DO - 10.1016/j.addma.2018.07.004

M3 - Review article

AN - SCOPUS:85052479458

VL - 23

SP - 319

EP - 328

JO - Additive Manufacturing

JF - Additive Manufacturing

SN - 2214-8604

ER -